Stem-cell transplantation in chronic lymphocytic leukemia: The time for designing randomized studies has arrived

Seminars in Oncology

Volumn 26, Issue 1, 1999, Pages 48-61

  Waselenko, J K ^a   Flynn, J M ^a   Byrd, J C ^a  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUDARABINE;

ALLOGENIC BONE MARROW TRANSPLANTATION; AUTOLOGOUS BONE MARROW TRANSPLANTATION; CANCER RECURRENCE; CHRONIC LYMPHATIC LEUKEMIA; HUMAN; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; REVIEW; STEM CELL TRANSPLANTATION;

ANTINEOPLASTIC AGENTS; BONE MARROW; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; LEUKEMIA, LYMPHOCYTIC, CHRONIC; PATIENT SELECTION; RANDOMIZED CONTROLLED TRIALS; RESEARCH DESIGN; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS; TREATMENT OUTCOME;

EID: 0032984947     PISSN: 00937754     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (105)